Mixing cells for vascularized kidney regeneration

Michael Namestnikov, Oren Pleniceanu, Benjamin Dekel

Research output: Contribution to journalReview articlepeer-review


The worldwide rise in prevalence of chronic kidney disease (CKD) demands innovative bio-medical solutions for millions of kidney patients. Kidney regenerative medicine aims to replenish tissue which is lost due to a common pathological pathway of fibrosis/inflammation and rejuvenate remaining tissue to maintain sufficient kidney function. To this end, cellular therapy strategies devised so far utilize kidney tissue-forming cells (KTFCs) from various cell sources, fetal, adult, and pluripotent stem-cells (PSCs). However, to increase engraftment and potency of the transplanted cells in a harsh hypoxic diseased environment, it is of importance to co-transplant KTFCs with vessel forming cells (VFCs). VFCs, consisting of endothelial cells (ECs) and mesenchymal stem-cells (MSCs), synergize to generate stable blood vessels, facilitating the vascularization of self-organizing KTFCs into renovascular units. In this paper, we review the different sources of KTFCs and VFCs which can be mixed, and report recent advances made in the field of kidney regeneration with emphasis on generation of vascularized kidney tissue by cell transplantation.

Original languageEnglish
Article number1119
Issue number5
StatePublished - May 2021


  • Cellular therapy
  • IPSCs organoids
  • Kidney regeneration
  • Stem-cells
  • Vascularization

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Mixing cells for vascularized kidney regeneration'. Together they form a unique fingerprint.

Cite this